Replies to post #54650 on Biotech Values

[DewDiligence]

>MNTA – Can the FDA's concerns over immunogenicity be alleviated by anything other than clinical trials?<

Maybe. We’ll know in a month or two when Sandoz and MNTA meet with the FDA.